Comparison of the Efficacy of Apraclonidine and Brimonidine as Aqueous Suppressants in Humans
Ramin Schadlu;
Todd L. Maus, MD;
Cherie B. Nau, BS;
Richard F. Brubaker, MD
Arch Ophthalmol. 1998;116:1441-1444.
Objective To measure and compare the effect of apraclonidine hydrochloride and brimonidine tartrate on the rate of aqueous humor flow in human subjects.
Subjects and Methods Forty normal human subjects were given apraclonidine or brimonidine by topical instillation. Aqueous humor flow was measured by the rate of disappearance of topically applied fluorescein. Intraocular pressure was measured by applanation tonometry.
Results Apraclonidine suppressed aqueous humor flow between 39% and 44% and lowered intraocular pressure between 20% and 23%. Brimonidine suppressed aqueous humor flow between 44% and 48% and lowered intraocular pressure between 19% and 22%.
Conclusion No statistically significant differences were found between the effects of the 2 drugs on aqueous humor dynamics in normal subjects.
From the Department of Ophthalmology, Mayo Clinic and Mayo Foundation, Rochester, Minn. Mr Schadlu is currently a candidate for a medical degree at the Heinrich-Heine-Universitaet, Dusseldorf, Germany.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Aqueous Humor Flow in Normal Human Eyes Treated With Brimonidine and Dorzolamide, Alone and in Combination
Tsukamoto and Larsson
Arch Ophthalmol 2004;122:190-193.
ABSTRACT
| FULL TEXT
Potent {alpha}2A-Adrenoceptor-Mediated Vasoconstriction by Brimonidine in Porcine Ciliary Arteries
Wikberg-Matsson and Simonsen
IOVS 2001;42:2049-2055.
ABSTRACT
| FULL TEXT
Aqueous Humor Flow in Normal Human Eyes Treated With Brimonidine and Timolol, Alone and in Combination
Larsson
Arch Ophthalmol 2001;119:492-495.
ABSTRACT
| FULL TEXT
Hydroxyamphetamine Increases Intraocular Pressure in Rabbits
Okada and Gregory
Arch Ophthalmol 2001;119:235-239.
ABSTRACT
| FULL TEXT
Characterization of {alpha}2 Adrenergic Receptor Subtypes in Human Ocular Tissue Homogenates
Bylund and Chacko
IOVS 1999;40:2299-2306.
ABSTRACT
| FULL TEXT
Comparison of the Early Effects of Brimonidine and Apraclonidine as Topical Ocular Hypotensive Agents
Maus et al.
Arch Ophthalmol 1999;117:586-591.
ABSTRACT
| FULL TEXT
Assessment of Ocular Hypotensive Mechanisms and Additivity of Antiglaucoma Drugs in Humans
Kaufman
Arch Ophthalmol 1999;117:673-674.
FULL TEXT
|
